Cargando…
Fabry disease in the Spanish population: observational study with detection of 77 patients
BACKGROUND: Fabry disease is a multisystemic lysosomal storage disorder caused by the impairment of α-galactosidase A. The incidence of this rare disease is underestimated due to delayed diagnosis. Moreover, the management of the identified subjects is often complicated by the detection of variants...
Autores principales: | Vieitez, Irene, Souto-Rodriguez, Olga, Fernandez-Mosquera, Lorena, San Millan, Beatriz, Teijeira, Susana, Fernandez-Martin, Julian, Martinez-Sanchez, Felisa, Aldamiz-Echevarria, Luis Jose, Lopez-Rodriguez, Monica, Navarro, Carmen, Ortolano, Saida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891901/ https://www.ncbi.nlm.nih.gov/pubmed/29631605 http://dx.doi.org/10.1186/s13023-018-0792-8 |
Ejemplares similares
-
Morphological Hallmarks of Classical Fabry Disease: An Ultrastructural Study in a Large Spanish Family
por: San Millán-Tejado, Beatriz, et al.
Publicado: (2023) -
Systemic Treatment of Fabry Disease Using a Novel AAV9 Vector Expressing α-Galactosidase A
por: Biferi, Maria Grazia, et al.
Publicado: (2020) -
Spinal muscular atrophy with respiratory distress type 1 (SMARD1) : Report of a Spanish case with extended clinicopathological follow-up
por: San Millan, Beatriz, et al.
Publicado: (2016) -
Fabry Disease and Central Nervous System Involvement: From Big to Small, from Brain to Synapse
por: Cortés-Saladelafont, Elisenda, et al.
Publicado: (2023) -
Description of the first Spanish case of Gerstmann–Sträussler–Scheinker disease with A117V variant: clinical, histopathological and biochemical characterization
por: Eraña, Hasier, et al.
Publicado: (2022)